SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,768.85 187.85
( 0.24%)

Global Indices

Nasdaq

54,370.92 264.04
(0.49%)

Dow Jones

7,742.03 -15.49
(-0.20%)

Hang Seng

66,265.57 2,308.04
(3.61%)

Nikkei 225

10,894.52 15.14
(0.14%)

Forex

USD-INR

95.29 -0.10
(-0.11%)

EUR-INR

109.78 -0.22
(-0.20%)

GBP-INR

128.18 -0.43
(-0.33%)

JPY-INR

0.61 0.00
(0.31%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

276.4035981

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

36.67

906.19

EPS(TTM)

Face Value()

Div & Yield %

20.97

0.07

Back

bayer cropscience ltd

Anmol India standalone net profit rises 673.68% in the December 2025 quarter

Feb 12,2026

Net profit of Anmol India rose 673.68% to Rs 2.94 crore in the quarter ended December 2025 as against Rs 0.38 crore during the previous quarter ended December 2024. Sales rose 19.67% to Rs 303.16 crore in the quarter ended December 2025 as against Rs 253.32 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	303.16	253.32	20
OPM %	1.70	0.88	-
PBDT	4.11	0.61	574
PBT	3.93	0.51	671
NP	2.94	0.38	674

78,768.85 187.85 ( 0.24%)

54,370.92 264.04 (0.49%)

7,742.03 -15.49 (-0.20%)

66,265.57 2,308.04 (3.61%)

10,894.52 15.14 (0.14%)

95.29 -0.10 (-0.11%)

109.78 -0.22 (-0.20%)

128.18 -0.43 (-0.33%)

0.61 0.00 (0.31%)